IPG7236 or anti-PD-L1 monotherapy slightly delayed tumor progression, but this effect did not persist beyond day 9, and tumor volume ultimately approached the level observed in the control group (~1, 800 mm3). This evidence concerns the gene CD274 and neoplasm.